Niagen Bioscience
NAGE
64 hedge funds and large institutions have $40.9M invested in Niagen Bioscience in 2018 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 20 increasing their positions, 12 reducing their positions, and 7 closing their positions.
67% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 12
23% more capital invested
Capital invested by funds: $33.2M → $40.9M (+$7.67M)
1.03% more ownership
Funds ownership: 16.3% → 17.33% (+1%)
0% more funds holding
Funds holding: 64 → 64 (0)
0% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northern Trust
Chicago,
Illinois
|
+$1.23M |
| 2 |
TCM
Tieton Capital Management
Yakima,
Washington
|
+$741K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$379K |
| 4 |
State Street
Boston,
Massachusetts
|
+$151K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$147K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$338K |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$164K |
| 3 |
NSIM
North Star Investment Management
Chicago,
Illinois
|
-$152K |
| 4 |
Morgan Stanley
New York
|
-$95.5K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$55K |
NAGE Hedge Fund Activity: Q3 2018 in Review
64 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Niagen Bioscience (NAGE) for Q3 2018, worth a combined $40.9M — up 23% from $33.2M a quarter earlier.
Fund positioning in NAGE was balanced in Q3 2018: 7 funds opened new positions, 7 closed out, 20 added to existing stakes and 12 trimmed.
The largest buyer was Northern Trust, adding an estimated $1.23M. The largest seller was Wells Fargo, cutting an estimated $338K.
- 64 institutional investors held Niagen Bioscience (NAGE) as of Q3 2018, unchanged from Q2 2018.
- Funds reported $40.9M of Niagen Bioscience stock for Q3 2018, up 23% quarter-over-quarter.
- 7 funds opened new Niagen Bioscience positions in Q3 2018 and 7 closed out, a net change of 0 holders.
- The largest Niagen Bioscience buyer in Q3 2018 was Northern Trust, an estimated $1.23M added.
- The largest Niagen Bioscience seller in Q3 2018 was Wells Fargo, an estimated $338K sold.
Based on aggregated 13F filings for Q3 2018.